Purchase Order SPE2DP26P0630

<p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Fenwal, Inc. for blood packs with anticoagulant, valued at $2,334.42, with an award date of March 25, 2026 and ultimate completion date of June 23, 2026. Work is performed in Lake Zurich, Illinois. This is a firm fixed-price purchase order with no set-aside.</p>

This is a $1,101.28 firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products based in Lake Zurich, Illinois. The contract is for the delivery of &quot;BLOOD PACK WITH ANT&quot; and has an ultimate completion date of January 30, 2025. Fenwal, Inc. is a global blood technology company and a key supplier to various federal agencies, providing critical medical supplies and equipment that support...

Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...

<p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to Fenwal, Inc. for anticoagulant citrate products on March 10, 2026, with a ceiling value of $2,428.32. Performance is to be completed by March 16, 2026, and work is performed in Lake Zurich, Illinois.</p>

The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order valued at $3,967.24 to Fenwal, Inc. for a hand blood sealer on November 7, 2025, with an ultimate completion date of December 1, 2025. The contract, issued without set-aside designation, reflects Fenwal's established position as a specialized supplier of blood collection, separation, storage, and transfusion products to federal health agencies. Fenwal, a subsidiary of Fresenius Kabi headquartered...

The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, valued at $1,673.88, is for the supply of washing solution, a medical consumable used in transfusion medicine and cell therapy applications. The contract has an ultimate completion date of May 10, 2024 and was awarded on April 10, 2024 without any set-aside designation....

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract, valued at $41,848.64, is for the delivery of blood packs with anticoagulants to support the agency's medical supply chain operations. Fenwal, Inc. is a registered federal vendor that has consistently secured contracts from various agencies, including the DLA, National...

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical supplies, for the delivery of blood packs with anticoagulant. The contract has a ceiling value of $3,303.84 and an ultimate completion date of August 18, 2025. Fenwal, Inc. is a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The company is a registered vendor with the U.S. federal...

This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $3,347.76 contract is for the delivery of washing solution, FR (federal supply code 8510539296), with a completion date of June 3, 2024. Fenwal, Inc. has an extensive history of providing blood collection, separation, storage, and transfusion products and services to various federal agencies, including the Department of...